Literature DB >> 29759454

Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.

E Kevin Heist1, Andres Belalcazar2, Wyatt Stahl3, Tom F Brouwer4, Reinoud E Knops4.   

Abstract

OBJECTIVES: This study determined the impact of subcutaneous implantable cardioverter-defibrillator (S-ICD) coil and generator position on defibrillation threshold (DFT).
BACKGROUND: S-ICD implantation can occasionally result in unacceptably high DFT. Implant position characteristics associated with high DFTs in S-ICD patients have not been fully elucidated.
METHODS: A 3.8-million-element computer model built from magnetic resonance images was used to simulate the electric fields that occur during defibrillation. Generator positions were tested from posterior to anterior in 4-cm increments. The left parasternal coil was tested with 0, 5, and 10 mm of underlying subcutaneous fat and the generator with 20 mm of underlying fat. The estimated DFT for the S-ICD was defined as the energy delivered when producing an electric field of 4 volts/cm in at least 95% of the ventricular myocardium.
RESULTS: Estimated DFTs were 22, 29, 64, and 135 joules for posterior, standard (lateral), mid-anterior, and anterior generator locations, respectively. Defibrillation thresholds were 29, 58, and 95 joules with 0, 5, and 10 mm subcoil fat, respectively, and 45 joules with 20 mm subgenerator fat. Combining anterior generator position with subcoil fat resulted in a very high DFT (379 joules). Shock impedance increased with both subcoil and subgenerator fat but was minimally affected by anterior/posterior generator position.
CONCLUSIONS: The model suggests that an S-ICD implantation strategy involving posterior generator location and coil and generator directly over the fascia without underlying fat is likely to markedly lower DFTs with the S-ICD and assist in troubleshooting of patients with unacceptably high DFTs.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  S-ICD; T-ICD; defibrillation threshold; subcutaneous implantable cardioverter-defibrillator; transvenous implantable cardioverter-defibrillator

Mesh:

Year:  2017        PMID: 29759454     DOI: 10.1016/j.jacep.2016.10.016

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  12 in total

Review 1.  The Saga of Defibrillation Testing: When Less Is More.

Authors:  Marye J Gleva; Melissa Robinson; Jeanne Poole
Journal:  Curr Cardiol Rep       Date:  2018-05-05       Impact factor: 2.931

2.  Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.

Authors:  Daniel J Friedman; Craig S Parzynski; E Kevin Heist; Andrea M Russo; Joseph G Akar; James V Freeman; Jeptha P Curtis; Sana M Al-Khatib
Journal:  Circulation       Date:  2018-02-20       Impact factor: 29.690

3.  Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.

Authors:  Pier D Lambiase; Dominic A Theuns; Francis Murgatroyd; Craig Barr; Lars Eckardt; Petr Neuzil; Marcoen Scholten; Margaret Hood; Jȕrgen Kuschyk; Amy J Brisben; Nathan Carter; Timothy M Stivland; Reinoud Knops; Lucas V A Boersma
Journal:  Eur Heart J       Date:  2022-06-01       Impact factor: 35.855

4.  Revision of subcutaneous implantable cardioverter defibrillator to intermuscular pocket to prevent inappropriate shocks.

Authors:  Jeko M Madjarov; Svetozar Madzharov; Filip Abedinov; Stefanie Chappuis; John M Fedor
Journal:  Clin Case Rep       Date:  2020-04-15

5.  Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks.

Authors:  Mauro Biffi; Matteo Ziacchi; Andrea Angeletti; Andrea Castelli; Giulia Massaro; Cristian Martignani; Mariolina Lovecchio; Sergio Valsecchi; Igor Diemberger
Journal:  Clin Cardiol       Date:  2019-04-25       Impact factor: 2.882

6.  Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.

Authors:  Federico Migliore; Giulia Mattesi; Pietro De Franceschi; Giuseppe Allocca; Martino Crosato; Vittorio Calzolari; Mauro Fantinel; Benedetta Ortis; Domenico Facchin; Elisabetta Daleffe; Tommaso Fabris; Elena Marras; Manuel De Lazzari; Francesco Zanon; Lina Marcantoni; Mariachiara Siciliano; Domenico Corrado; Sabino Iliceto; Emanuele Bertaglia; Massimo Zecchin
Journal:  J Cardiovasc Electrophysiol       Date:  2019-03-13

7.  Safety and efficacy aspects of pulsed field ablation catheters as a function of electrode proximity to blood and energy delivery method.

Authors:  Andres Belalcazar
Journal:  Heart Rhythm O2       Date:  2021-10-13

8.  An in-silico assessment of efficacy of two novel intra-cardiac electrode configurations versus traditional anti-tachycardia pacing therapy for terminating sustained ventricular tachycardia.

Authors:  Shuang Qian; Adam Connolly; Caroline Mendonca-Costa; Fernando Campos; Steven E Williams; John Whitaker; Christopher A Rinaldi; Martin J Bishop
Journal:  Comput Biol Med       Date:  2021-10-30       Impact factor: 4.589

9.  A computational investigation into rate-dependant vectorcardiogram changes due to specific fibrosis patterns in non-ischæmic dilated cardiomyopathy.

Authors:  Philip M Gemmell; Karli Gillette; Gabriel Balaban; Ronak Rajani; Edward J Vigmond; Gernot Plank; Martin J Bishop
Journal:  Comput Biol Med       Date:  2020-07-04       Impact factor: 4.589

10.  Complications related to elective generator replacement of the subcutaneous implantable defibrillator.

Authors:  Willeke van der Stuijt; Anne-Floor B E Quast; Sarah W E Baalman; Koen C de Wilde; Tom F Brouwer; Arthur A M Wilde; Reinoud E Knops
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.